SecBot SecBot
PRESS-RELEASE ·Filed Mar 10, 2026

SSII

SS Innovations
BULLISH
Impact 8/10
Horizonmonths Processed7mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▲ Bullish

The combination of accelerating revenue growth, margin improvement, and successful capital raise positions SSII for potential upside as it advances U.S. and EU market entry. Traders should monitor FDA and CE marking timelines as key catalysts.

DirectionBullish
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
SSII ▼ -2.49% at T+60d
LONG call ✗ call lost -2.49% · α vs SPY -14.17% · entry $4.42 → $4.31
Entry = T+0 close
Mar 10, 2026
via day close
T+1d
+9.73%
call +9.73% · α +9.83%
$4.85
settled 8mo ago
T+5d
+7.47%
call +7.47% · α +8.37%
$4.75
settled 7mo ago
T+20d
-2.71%
call -2.71% · α -2.56%
$4.30
settled 7mo ago
T+60d
-2.49%
call -2.49% · α -14.17%
$4.31
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

SS Innovations reported strong full-year 2025 revenue growth of 105.7% to $42.5 million with expanding gross margins and a significantly reduced net loss, driven by a 119.1% increase in robotic system installations. The company also announced a $18.6 million private placement completed in March 2026, enhancing its cash position to fund global expansion and U.S./EU regulatory approvals.

Key Financial Metrics

Revenue
$42.5M
+105.7% YoY
EPS
$-0.06
Deal Value
$18.6M

Key Facts

  • Full-year 2025 revenue grew 105.7% YoY to $42.5 million
  • Gross margin expanded to 46.0% from 40.9% in 2024
  • Net loss narrowed to $12.1 million from $19.2 million in 2024
  • SSi Mantra installations increased 119.1% to 103 in 2025
  • Company raised $18.6 million in gross proceeds via private placement in March 2026
  • FDA 510(k) review for SSi Mantra expected to conclude by mid-2026

Financial Impact

Revenue more than doubled with margin expansion and loss reduction; $18.6M capital raise strengthens balance sheet

revenuegross marginnet losscash positiondilution

Risk Factors

  • Continuing net losses despite improvement
  • Heavy reliance on future regulatory approvals in major markets
  • Foreign currency translation risk evident in comprehensive loss

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3252830
22 reports for SSII
Performance horizon
50% Hit rate @ T+5 2 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +15.17%May 20, 2026
Filters
Rows
Reports for SSII — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 3/10
$2.35awaiting T+5—$2.37 (+0.85%)
Oct 26, 2026
today
Press Release
NEUTRAL ★ 3/10
$2.35awaiting T+5—$2.37 (+0.85%)
Oct 13, 2026
13d ago
8-K
NEUTRAL ★ 4/10
$2.55 $2.54▼ −0.39%▲ +0.76%$2.37 (−7.06%)
Oct 13, 2026
13d ago
8-K
BEARISH ★ 6/10
$2.55 $2.54▲ +0.39%▼ −0.76%$2.37 (+7.06%)
Oct 9, 2026
17d ago
424B5
BEARISH ★ 6/10
$2.55 $2.45▲ +3.92%▲ +2.43%$2.37 (+7.06%)
Oct 5, 2026
21d ago
8-K
NEUTRAL ★ 4/10
$2.77 $2.55▼ −7.94%▼ −8.36%$2.37 (−14.44%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$3.30 $3.26▼ −1.21%▼ −0.71%$2.37 (−28.18%)
Aug 13, 2026
10w ago
8-K
MIXED ★ 6/10
$3.83 $3.61▼ −5.74%▼ −3.78%$2.37 (−38.12%)
Jul 17, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$3.64 $3.57▼ −1.92%▼ −1.24%$2.37 (−34.89%)
Jul 14, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$3.67 $3.75▲ +2.18%▲ +3.48%$2.37 (−35.42%)
Showing 10 of 22

US Market Status

Market Closed — Opens in 8h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 10, 2026